350 related articles for article (PubMed ID: 33565962)
1. Enhancing mitochondrial activity in neurons protects against neurodegeneration in a mouse model of multiple sclerosis.
Rosenkranz SC; Shaposhnykov AA; Träger S; Engler JB; Witte ME; Roth V; Vieira V; Paauw N; Bauer S; Schwencke-Westphal C; Schubert C; Bal LC; Schattling B; Pless O; van Horssen J; Freichel M; Friese MA
Elife; 2021 Feb; 10():. PubMed ID: 33565962
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of neuronal PGC-1α ameliorates cognitive impairment induced by chronic cerebral hypoperfusion.
Han B; Jiang W; Liu H; Wang J; Zheng K; Cui P; Feng Y; Dang C; Bu Y; Wang QM; Ju Z; Hao J
Theranostics; 2020; 10(6):2832-2848. PubMed ID: 32194838
[No Abstract] [Full Text] [Related]
4. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Mao P; Manczak M; Shirendeb UP; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
[TBL] [Abstract][Full Text] [Related]
5. Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
Nijland PG; Witte ME; van het Hof B; van der Pol S; Bauer J; Lassmann H; van der Valk P; de Vries HE; van Horssen J
Acta Neuropathol Commun; 2014 Dec; 2():170. PubMed ID: 25492529
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.
Witte ME; Nijland PG; Drexhage JA; Gerritsen W; Geerts D; van Het Hof B; Reijerkerk A; de Vries HE; van der Valk P; van Horssen J
Acta Neuropathol; 2013 Feb; 125(2):231-43. PubMed ID: 23073717
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of PGC-1α in neurons protects against experimental autoimmune encephalomyelitis.
Dang C; Han B; Li Q; Han R; Hao J
FASEB J; 2019 Dec; 33(12):14811-14824. PubMed ID: 31718280
[TBL] [Abstract][Full Text] [Related]
8. PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons.
Wareski P; Vaarmann A; Choubey V; Safiulina D; Liiv J; Kuum M; Kaasik A
J Biol Chem; 2009 Aug; 284(32):21379-85. PubMed ID: 19542216
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-γ coactivator-1α mediates neuroprotection against excitotoxic brain injury in transgenic mice: role of mitochondria and X-linked inhibitor of apoptosis protein.
Mäkelä J; Mudò G; Pham DD; Di Liberto V; Eriksson O; Louhivuori L; Bruelle C; Soliymani R; Baumann M; Korhonen L; Lalowski M; Belluardo N; Lindholm D
Eur J Neurosci; 2016 Mar; 43(5):626-39. PubMed ID: 26741810
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics.
Varghese M; Zhao W; Trageser KJ; Pasinetti GM
Biomolecules; 2020 May; 10(5):. PubMed ID: 32414179
[TBL] [Abstract][Full Text] [Related]
11. Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults.
Hasegawa K; Yasuda T; Shiraishi C; Fujiwara K; Przedborski S; Mochizuki H; Yoshikawa K
Nat Commun; 2016 Mar; 7():10943. PubMed ID: 26971449
[TBL] [Abstract][Full Text] [Related]
12. PGC-1α deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI.
Fontecha-Barriuso M; Martín-Sánchez D; Martinez-Moreno JM; Carrasco S; Ruiz-Andrés O; Monsalve M; Sanchez-Ramos C; Gómez MJ; Ruiz-Ortega M; Sánchez-Niño MD; Cannata-Ortiz P; Cabello R; Gonzalez-Enguita C; Ortiz A; Sanz AB
J Pathol; 2019 Sep; 249(1):65-78. PubMed ID: 30982966
[TBL] [Abstract][Full Text] [Related]
13. PGC-1α, mitochondrial dysfunction, and Huntington's disease.
Johri A; Chandra A; Flint Beal M
Free Radic Biol Med; 2013 Sep; 62():37-46. PubMed ID: 23602910
[TBL] [Abstract][Full Text] [Related]
14. PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein.
Ciron C; Zheng L; Bobela W; Knott GW; Leone TC; Kelly DP; Schneider BL
Acta Neuropathol Commun; 2015 Apr; 3():16. PubMed ID: 25853296
[TBL] [Abstract][Full Text] [Related]
15. Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function.
Ciron C; Lengacher S; Dusonchet J; Aebischer P; Schneider BL
Hum Mol Genet; 2012 Apr; 21(8):1861-76. PubMed ID: 22246294
[TBL] [Abstract][Full Text] [Related]
16. Neuronal inactivation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) protects mice from diet-induced obesity and leads to degenerative lesions.
Ma D; Li S; Lucas EK; Cowell RM; Lin JD
J Biol Chem; 2010 Dec; 285(50):39087-95. PubMed ID: 20947495
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α.
Wang Y; Zhao X; Lotz M; Terkeltaub R; Liu-Bryan R
Arthritis Rheumatol; 2015 May; 67(8):2141-53. PubMed ID: 25940958
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Mitochondrial Dysfunction in Experimental Autoimmune Encephalomyelitis (EAE) Models of Multiple Sclerosis.
Ng X; Sadeghian M; Heales S; Hargreaves IP
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600882
[TBL] [Abstract][Full Text] [Related]
19. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
[TBL] [Abstract][Full Text] [Related]
20. Neuronal mitochondrial calcium uniporter deficiency exacerbates axonal injury and suppresses remyelination in mice subjected to experimental autoimmune encephalomyelitis.
Holman SP; Lobo AS; Novorolsky RJ; Nichols M; Fiander MDJ; Konda P; Kennedy BE; Gujar S; Robertson GS
Exp Neurol; 2020 Nov; 333():113430. PubMed ID: 32745471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
